Chief Medical Officer, Zealand Pharma
Appears in 1 story
Leading clinical development of glepaglutide
Zealand Pharma's Zeydovio is one step from market in Europe. On September 17, the European Medicines Agency's scientific committee recommended approving the twice-weekly injection for adults with short bowel syndrome.
Updated 2 hours ago
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
